Skip to main content
Equibles

Ikarian Capital, LLC

Position in CMMB — Chemomab Therapeutics Ltd.

CIK 1778253 DALLAS, TX
Back to CMMB Full portfolio

Position in CMMB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$83,904
+$2,589 QoQ
Shares Held
51,793
0.0% QoQ
Ownership
0.707%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4
of 13 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CMMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. CMMB ranks #100 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 328,635 $43,793,900
2 KOD
Kodiak Sciences Inc.
 1,059,730 $41,287,080
3 ALMS
Alumis Inc.
 870,548 $24,497,220
4 PRAX
Praxis Precision Medicines, Inc.
 72,842 $24,386,773
5 PCVX
Vaxcyte, Inc.
 388,682 $22,594,084
6 CLDX
Celldex Therapeutics, Inc.
 478,500 $17,804,985
7 RCUS
Arcus Biosciences, Inc.
 504,559 $15,555,553
8 RLMD
Relmada Therapeutics, Inc.
 2,148,359 $14,866,644

All Filings in CMMB

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $83,904 51,793
2026-03-31 $81,315 51,793
2025-12-31 $85,458 51,793
2025-09-30 $140,079 53,262
2025-06-30 $247,140 213,052
2025-03-31 $232,226 213,052
2024-12-31 $385,624 213,052
2024-09-30 $335,025 213,392
2024-06-30 $194,613 213,392
2024-03-31 $166,232 213,392
2023-12-31 $108,829 213,392
2023-09-30 $190,985 213,392
2023-06-30 $280,610 213,392
2023-03-31 $376,367 236,709
2022-12-31 $1,002,854 313,392
2022-09-30 $612,281 245,896
2022-06-30 $991,984 268,104
2022-03-31 $1,286,899 268,104
2021-12-31 $1,830,321 265,264
2021-09-30 $3,160,725 285,264
2021-06-30 $5,525,956 290,534